Status:
NOT_YET_RECRUITING
An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph
Lead Sponsor:
Joseph D. Tobias
Conditions:
Surgery
Eligibility:
All Genders
28-25 years
Phase:
NA
Brief Summary
The goal of this study is to use electromyography-based train-of-four monitoring (TetraGraph™ Neuromuscular Transmission Monitor) as a means of evaluating differences in neuromuscular transmission bet...
Eligibility Criteria
Inclusion
- ASA 1-3 patients
- Aged 28 days - 3 months or ≥ 12 years
- Undergoing a surgical procedure with a volatile-agent based anesthetic that does not require administration of a neuromuscular blocking agent
Exclusion
- Patients with history of a peripheral neurologic or neuropathic disorder
- Patients in whom the upper extremity cannot be used for TOF monitoring
- Patients undergoing a surgical procedure in which neuromuscular blockade is required
- Edematous patients
- Patients receiving total intravenous anesthesia (TIVA)
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07133412
Start Date
January 1 2026
End Date
December 1 2027
Last Update
October 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205